Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Merck
Fuji
Daiichi Sankyo
Citi
Express Scripts
Mallinckrodt
Covington
Colorcon

Generated: June 19, 2018

DrugPatentWatch Database Preview

SERPASIL-ESIDRIX Drug Profile

« Back to Dashboard

When do Serpasil-esidrix patents expire, and what generic alternatives are available?

Serpasil-esidrix is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in SERPASIL-ESIDRIX is hydrochlorothiazide; reserpine. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; reserpine profile page.
Summary for SERPASIL-ESIDRIX
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:SERPASIL-ESIDRIX at DailyMed
Drug patent expirations by year for SERPASIL-ESIDRIX

US Patents and Regulatory Information for SERPASIL-ESIDRIX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis SERPASIL-ESIDRIX #1 hydrochlorothiazide; reserpine TABLET;ORAL 011878-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis SERPASIL-ESIDRIX #2 hydrochlorothiazide; reserpine TABLET;ORAL 011878-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Army
Cerilliant
McKesson
Cantor Fitzgerald
Chinese Patent Office
Mallinckrodt
Teva
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.